Phosphorylation chemistry of the Bordetella PlrSR TCS and its contribution to bacterial persistence in the lower respiratory tract
S. A. Barr, E. N. Kennedy, L. S. McKay, R. M. Johnson, R. J. Ohr, P. A. Cotter, R. B. Bourret
Abstract
2Bordetella species cause lower respiratory tract infections in mammals. B. pertussis and B. bronchiseptica are the causative agents of whooping cough and kennel cough, respectively. The current acellular vaccine for B. pertussis protects against the pertussis toxin but does not prevent transmission or colonization. Cases of B. pertussis infections are on the rise even in areas of high vaccination. The PlrSR two-component system, is required for persistence in the mouse lung. A partial plrS deletion strain and a plrS H521Q strain cannot survive past three days in the lung, suggesting PlrSR works in a phosphorylation dependent mechanism. We characterized the biochemistry of B. bronchiseptica PlrSR and found that both proteins function as a canonical two-component system. His521 and Glu522 were essential for PlrS autophosphorylation. Asn525 was essential for phosphatase activity. The PAS domain was critical for both PlrS autophosphorylation and phosphatase activities. PlrS can both phosphotransfer to and exert phosphatase activity towards PlrR. Unexpectedly, PlrR forms a tetramer when unphosphorylated and a dimer upon phosphorylation. Finally, we demonstrated the importance of PlrS phosphatase activity for persistence within the murine lung. By characterizing PlrSR we hope to guide future in vivo investigation for development of new vaccines and therapeutics. 10 GRAPHICAL ABSTRACT O_FIG_DISPLAY_L [Figure 1] M_FIG_DISPLAY C_FIG_DISPLAY
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Genetic evidence for a periplasmic protein as a component for a subset of NtrYX two-component systems
Alexa R. Wolber, Liliana S. McKay, … Peggy A. Cotter·bioRxiv·Nov 7, 2025
- Opposing effects of acellular and whole cell pertussis vaccines on Bordetella pertussis biofilm formation, Siglec-F+ neutrophil recruitment and bacterial clearance in mouse nasal tissues
Jesse M. Hall, Jessica Lizzeth Gutiérrez-Ferman, … Purnima Dubey·bioRxiv·Jan 23, 2024
- A Novel Adhesin of B. pertussis is Key to Colonisation of Epithelial Cells
Michael Gollan, Mónica Cartelle Gestal, … Iain MacArthur·bioRxiv·Sep 23, 2024
- Cytotoxicity of the effector protein BteA was attenuated in Bordetella pertussis by insertion of an alanine residue
J. Bayram, I. Malcova, … J. Kamanova·PLOS PathogensPeer-reviewed·Aug 10, 2020
- Bps polysaccharide of Bordetella pertussis resists antimicrobial peptides by functioning as a dual surface shield and decoy and converts Escherichia coli into a respiratory pathogen.
A. R. Fullen, J. L. Gutierrez-Ferman, … R. Deora·bioRxiv·Apr 6, 2022
- A dual role for PGLYRP1 in host defense and immune regulation during B. pertussis infection
David M. Rickert, Sasha Cardozo, … Ciaran M. Skerry·bioRxiv·Sep 26, 2025